131 related articles for article (PubMed ID: 23226798)
21. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
[TBL] [Abstract][Full Text] [Related]
22. [The growth inhibitory effect of non-steroid anti-inflammatory drugs on ovarian cancer].
Wang HJ; Peng ZL; Liu XQ; Yang KX; Lou JY; Luo FM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):428-32. PubMed ID: 17593823
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
Tuynman JB; Buskens CJ; Kemper K; ten Kate FJ; Offerhaus GJ; Richel DJ; van Lanschot JJ
Ann Surg; 2005 Dec; 242(6):840-9, discussion 849-50. PubMed ID: 16327494
[TBL] [Abstract][Full Text] [Related]
24. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
Ohtsu N; Takaoka K; Segawa E; Hashitani S; Noguchi K; Kishimoto H; Urade M
Oncol Rep; 2010 Jul; 24(1):31-6. PubMed ID: 20514441
[TBL] [Abstract][Full Text] [Related]
25. [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].
Li Q; Peng J; Zhang GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1123-8. PubMed ID: 19141979
[TBL] [Abstract][Full Text] [Related]
26. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
Zhang DQ; Guo Q; Zhu JH; Chen WC
World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
[TBL] [Abstract][Full Text] [Related]
28. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
[TBL] [Abstract][Full Text] [Related]
29. [Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma].
Gao J; Li JS; Xu GL; Jia WD; Ma JL; Yu JH; Ge YS
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):900-4. PubMed ID: 21205474
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells.
Dhawan D; Jeffreys AB; Zheng R; Stewart JC; Knapp DW
Mol Cancer Ther; 2008 Apr; 7(4):897-904. PubMed ID: 18413803
[TBL] [Abstract][Full Text] [Related]
31. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
32. Different cell cycle modulation by celecoxib at different concentrations.
Kim YM; Pyo H
Cancer Biother Radiopharm; 2013 Mar; 28(2):138-45. PubMed ID: 23268707
[TBL] [Abstract][Full Text] [Related]
33. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
[TBL] [Abstract][Full Text] [Related]
34. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism].
Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281
[TBL] [Abstract][Full Text] [Related]
35. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.
Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G
Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
Cui W; Yu CH; Hu KQ
Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
[TBL] [Abstract][Full Text] [Related]
37. Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts.
Gong Y; Murphy LC; Murphy LJ
J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):13-9. PubMed ID: 8049128
[TBL] [Abstract][Full Text] [Related]
38. Combinational Treatment Effect of Tetrahydrocurcumin and Celecoxib on Cervical Cancer Cell-Induced Tumor Growth and Tumor Angiogenesis in Nude Mice.
Yoysungnoen B; Bhattarakosol O; Changtam C; Patumraj S
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S23-31. PubMed ID: 29916670
[TBL] [Abstract][Full Text] [Related]
39. Celecoxib-erlotinib combination treatment enhances radiosensitivity in A549 human lung cancer cell.
Sun J; Liu NB; Zhuang HQ; Zhao LJ; Yuan ZY; Wang P
Cancer Biomark; 2017; 19(1):45-50. PubMed ID: 28282799
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
